The stock market experienced further declines as both the Dow Jones and S&P 500 indices extended their losses from the previous trading session. Notably, Palantir Technologies saw a […]
Mattel Contemplates Price Increases Due to Tariffs
Barbie enthusiasts may soon face higher prices. Mattel CEO Ynon Kreiz announced that the toy manufacturer, known for Barbie and Hot Wheels, is considering raising U.S. toy prices […]
US Trade Deficit Widens in First Quarter Amid Rising Imports
The United States experienced an expansion in its trade deficit during the first quarter, influenced by rising imports and ongoing tariff policies. According to data released by the […]
Senate Democrats Propose Bill to Ban Federal Officials from Issuing Digital Assets
Senate Democrats have introduced a new bill aimed at prohibiting federal officials and their families from issuing digital assets. This move comes after they withdrew support for the […]
Palantir Stock Target Revamped Amid Post-Earnings Decline
Despite a strong quarter, Palantir Technologies faced a 12% stock decline post-earnings, nearing its biggest drop since May 7, 2024. For Q1 2025, Palantir reported adjusted earnings per […]
Senate’s Last-Ditch Effort to Save the GENIUS Act
The Senate is engaged in a final push to save the GENIUS Act, amid significant political debate. Top Democrats are expressing concerns over crypto legislation, particularly regarding ties […]
AMD Stock Price Analysis Amid Data Center Sales Surge
Advanced Micro Devices (AMD) shares experienced gains in extended trading following the release of first-quarter earnings that exceeded Wall Street expectations. The company’s data center segment sales surged […]
Dell Restructures Management to Flatten Organizational Hierarchy
Dell Technologies is restructuring its management hierarchy to create a flatter organizational model. Under the new structure, vice presidents and above will be required to manage at least […]
Ford Stock Reacts to Tariff Impact and Guidance Suspension
Ford Motor Company’s stock has shown little reaction to the company’s decision to suspend its 2025 financial guidance due to a significant $2.5 billion tariff impact. Analysts note […]
US FDA Appoints Vinay Prasad as Director of Biologics Evaluation and Research
The U.S. Food and Drug Administration (FDA) has appointed Vinay Prasad, a vocal critic of the agency and the pharmaceutical industry, as the new director of its Center […]